Phibro Animal Health (PAHC) Misses Q3 EPS by 5c; Trims FY16 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Phibro Animal Health Corporation Reports Third Quarter
May 9, 2016 4:17 PM EDTTEANECK, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its third quarter ended March 31, 2016.
Highlights for the March 2016 quarter (compared to the March 2015 quarter, excluding $2 million of prior-year vaccine licensing milestone revenue and income) Net sales of $183 million, a decrease of 1%Adjusted EBITDA of $29.7 million, an increase of 16%Adjusted diluted EPS of $0.38, an increase of 6%Â COMMENTARY
Our third quarter was a continuation of many of the trends we have seen recently, with our... More
